• Aspect Medical Systems (Norwood, Massachusetts) said that Boudewijn Bollen will retire from his role as president of international operations in 1Q08. After this time, Bollen will serve on a part-time basis as a senior company advisor and will remain a member of the board of directors. Bill Floyd, VP of sales and marketing for Aspect, will work with Bollen throughout a transition period starting in September 2007, and will be promoted to executive VP of worldwide sales and marketing upon Bollen’s retirement. Aspect specializes in brain monitoring technology.

Richard Gonzalez, president/COO, and a member of Abbott’s (Abbott Park, Illinois) board of directors, plans to retire after a 30-year career with the company. “Rick is a consummate leader and has had a distinguished career at Abbott, including his work to help conceive and execute Abbott’s successful medical products strategy,” said Miles White, CEO/chairman. Gonzalez will remain with Abbott until Sept. 30, 2007. Upon his retirement, the heads of Abbott’s four operating businesses — medical devices, pharmaceuticals, nutritionals and diagnostics — will report directly to White. Abbott specializes in pharmaceuticals and medical products, including nutritionals, devices and diagnostics.

Scott Bruder, MD, was named senior VP and chief technology officer of BD (Becton, Dickinson and Company; Franklin Lakes, New Jersey), effective Sept. 1. Bruder most recently was the worldwide VP for Johnson & Johnson Regenerative Therapeutics. BD is focused on improving drug therapy, enhancing the quality and speed of diagnosing infectious diseases, and advancing research and discovery of new drugs and vaccines.